346 related articles for article (PubMed ID: 8619026)
21. Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma.
Reuther T; Kübler AC; Zillmann U; Flechtenmacher C; Sinn H
Lasers Surg Med; 2001; 29(4):314-22. PubMed ID: 11746108
[TBL] [Abstract][Full Text] [Related]
22. Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma.
Lilge L; Molpus K; Hasan T; Wilson BC
Photochem Photobiol; 1998 Sep; 68(3):281-8. PubMed ID: 9747583
[TBL] [Abstract][Full Text] [Related]
23. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin.
Robinson DJ; de Bruijn HS; Star WM; Sterenborg HJ
Photochem Photobiol; 2003 Mar; 77(3):319-23. PubMed ID: 12685661
[TBL] [Abstract][Full Text] [Related]
24. Irradiance, Photofrin
Oakley E; Bellnier D; Hutson A; Cooper H; Habitzruther M; Sexton S; Curtin L; Tworek L; Mallory M; Henderson B; Shafirstein G
Photochem Photobiol; 2020 Mar; 96(2):397-404. PubMed ID: 31887227
[TBL] [Abstract][Full Text] [Related]
25. Monitoring interstitial m-THPC-PDT in vivo using fluorescence and reflectance spectroscopy.
Kruijt B; van der Ploeg-van den Heuvel A; de Bruijn HS; Sterenborg HJ; Amelink A; Robinson DJ
Lasers Surg Med; 2009 Nov; 41(9):653-64. PubMed ID: 19802884
[TBL] [Abstract][Full Text] [Related]
26. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer.
Morrison SA; Hill SL; Rogers GS; Graham RA
J Surg Res; 2014 Dec; 192(2):235-41. PubMed ID: 25043529
[TBL] [Abstract][Full Text] [Related]
28. Macroscopic singlet oxygen modeling for dosimetry of Photofrin-mediated photodynamic therapy: an in-vivo study.
Qiu H; Kim MM; Penjweini R; Zhu TC
J Biomed Opt; 2016 Aug; 21(8):88002. PubMed ID: 27552311
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
van der Veen N; Hebeda KM; de Bruijn HS; Star WM
Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study.
Baas P; Saarnak AE; Oppelaar H; Neering H; Stewart FA
Br J Dermatol; 2001 Jul; 145(1):75-8. PubMed ID: 11453910
[TBL] [Abstract][Full Text] [Related]
31. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
32. Intraperitoneal photodynamic therapy: comparison of red and green light distribution and toxicity.
Veenhuizen RB; Ruevekamp MC; Oppelaar H; Ransdorp B; van de Vijver M; Helmerhorst TJ; Kenemans P; Stewart FA
Photochem Photobiol; 1997 Sep; 66(3):389-95. PubMed ID: 9297983
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy as novel nephron sparing treatment option for small renal masses.
Kroeze SG; Grimbergen MC; Rehmann H; Bosch JL; Jans JJ
J Urol; 2012 Jan; 187(1):289-95. PubMed ID: 22099991
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC).
Mikvy P; Messman H; MacRobert AJ; Pauer M; Sams VR; Davies CL; Stewart JC; Bown SG
Br J Cancer; 1997; 76(6):713-8. PubMed ID: 9310235
[TBL] [Abstract][Full Text] [Related]
35. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
36. Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer.
Shafirstein G; Bellnier DA; Oakley E; Hamilton S; Habitzruther M; Tworek L; Hutson A; Spernyak JA; Sexton S; Curtin L; Turowski SG; Arshad H; Henderson B
Br J Cancer; 2018 Nov; 119(10):1191-1199. PubMed ID: 30353043
[TBL] [Abstract][Full Text] [Related]
37. Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light.
Pittet O; Petermann D; Michod D; Krueger T; Cheng C; Ris HB; Widmann C
J Photochem Photobiol B; 2007 Jul; 88(1):29-35. PubMed ID: 17560792
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.
Henderson BW; Sitnik-Busch TM; Vaughan LA
Photochem Photobiol; 1999 Jul; 70(1):64-71. PubMed ID: 10420844
[TBL] [Abstract][Full Text] [Related]
39. Continuous low-irradiance photodynamic therapy: a new therapeutic paradigm.
Rogers GS
J Natl Compr Canc Netw; 2012 Oct; 10 Suppl 2():S14-7. PubMed ID: 23055207
[TBL] [Abstract][Full Text] [Related]
40. Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy.
Huang Z; Chen Q; Shakil A; Chen H; Beckers J; Shapiro H; Hetzel FW
Photochem Photobiol; 2003 Nov; 78(5):496-502. PubMed ID: 14653582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
